Fortunato Bianconi

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 5.9K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study

Milena Sant, María Dolores Chirlaque López, Roberto Agresti et al. · European Journal of Cancer · 2015 · 270 citations · Full text

Genital Organs, Surgical Oncology, Breast Oncology +13

Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer

Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola et al. · Journal of Thoracic Oncology · 2011 · 176 citations · Full text

Kras Mutations, Medicine, Receptor Tyrosine Kinase +8

Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5

Lesley Anderson, Andrea Tavilla, Hermann Brenner et al. · European Journal of Cancer · 2015 · 175 citations · Full text

Small Intestine Cancers, Esophagus, Gastrointestinal Oncology +9

Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5

Côme Lepage, Riccardo Capocaccia, Monika Hackl et al. · European Journal of Cancer · 2015 · 147 citations

Primary Liver Cancer, Surgical Oncology, Pancreatic Cancer +11